Hereditary Fructose Intolerance
Overview
Plain-Language Overview
Hereditary Fructose Intolerance is a rare genetic condition that affects how the body processes a type of sugar called fructose, which is found in many fruits, vegetables, and sweeteners. It primarily impacts the liver and kidneys, where the body normally breaks down fructose for energy. People with this condition lack an important enzyme needed to safely digest fructose, leading to a buildup of harmful substances in the body. This can cause symptoms like severe nausea, vomiting, and low blood sugar after eating foods containing fructose. Over time, it can damage the liver and kidneys if fructose continues to be consumed. The condition usually appears in infancy or early childhood when fructose-containing foods are introduced. Managing the condition involves avoiding foods with fructose to prevent serious health problems.
Clinical Definition
Hereditary Fructose Intolerance (HFI) is an autosomal recessive metabolic disorder caused by a deficiency of the enzyme aldolase B, encoded by the ALDOB gene. This enzyme deficiency impairs the metabolism of fructose-1-phosphate, leading to its accumulation in hepatocytes and renal tubular cells. The toxic buildup results in hepatic dysfunction, hypoglycemia, and renal tubular damage. Clinically, HFI presents in infancy or early childhood with symptoms triggered by ingestion of fructose, sucrose, or sorbitol, including vomiting, abdominal pain, jaundice, and failure to thrive. If untreated, it can cause severe hepatic failure and renal impairment. The disorder highlights the importance of proper carbohydrate metabolism and the consequences of enzyme deficiencies in inherited metabolic diseases.
Inciting Event
Introduction of fructose, sucrose, or sorbitol in the diet triggers acute symptoms.
Consumption of fruit juices, honey, or processed foods containing fructose initiates metabolic crisis.
Administration of intravenous or oral medications containing fructose or sorbitol can precipitate symptoms.
Latency Period
Symptoms typically develop within hours after fructose ingestion.
Initial asymptomatic period lasts until fructose-containing foods are introduced in infancy or early childhood.
Repeated exposures lead to progressive worsening over days to weeks if fructose intake continues.
Diagnostic Delay
Symptoms are often misattributed to common causes of vomiting and hypoglycemia such as gastroenteritis or sepsis.
Lack of awareness about hereditary fructose intolerance leads to delayed consideration of metabolic causes.
Failure to link symptoms with dietary fructose exposure delays diagnosis.
Non-specific laboratory findings and absence of routine newborn screening contribute to diagnostic delay.
Clinical Presentation
Signs & Symptoms
Vomiting and abdominal pain shortly after ingestion of fructose-containing foods are hallmark symptoms.
Hypoglycemia causes sweating, irritability, and seizures in severe cases.
Failure to thrive and developmental delay may occur due to chronic nutritional deficiency.
Jaundice and hepatomegaly reflect liver dysfunction.
Lethargy and tremors can be signs of metabolic decompensation.
History of Present Illness
After ingestion of fructose-containing foods, patients develop nausea, vomiting, abdominal pain, and lethargy.
Progressive symptoms include hypoglycemia, jaundice, hepatomegaly, and failure to thrive.
Episodes of acute liver dysfunction and renal tubular acidosis may occur with continued fructose exposure.
Symptoms improve rapidly with fructose avoidance but recur upon re-exposure.
Past Medical History
History of feeding intolerance or vomiting after introduction of fruit juices or sweetened foods.
Episodes of hypoglycemia or unexplained liver dysfunction in infancy or early childhood.
No prior chronic illnesses unless complications from repeated fructose exposure have occurred.
Family History
Positive family history of similar symptoms or early childhood liver disease suggests autosomal recessive inheritance.
Consanguinity increases risk of affected siblings due to homozygous ALDOB mutations.
Known cases of hereditary fructose intolerance in siblings or close relatives support diagnosis.
Physical Exam Findings
Hepatomegaly due to accumulation of toxic metabolites in the liver is a common finding.
Jaundice may be present in severe cases due to liver dysfunction.
Hypoglycemia signs such as diaphoresis and lethargy may be observed during acute episodes.
Failure to thrive and poor growth are often noted in affected infants.
Tachycardia and signs of dehydration can occur during acute fructose ingestion episodes.
Diagnostic Workup
Diagnostic Criteria
Diagnosis of hereditary fructose intolerance is established by demonstrating deficient aldolase B enzyme activity in liver biopsy or by identifying pathogenic mutations in the ALDOB gene through genetic testing. Clinical suspicion arises from symptoms triggered by fructose ingestion, such as hypoglycemia and hepatomegaly. Laboratory findings often include elevated fructose-1-phosphate levels and abnormal liver function tests. A fructose tolerance test is contraindicated due to risk of severe hypoglycemia but historically supported diagnosis. Genetic confirmation is now the preferred and safest diagnostic approach.
Pathophysiology
Key Mechanisms
Deficiency of aldolase B enzyme leads to accumulation of fructose-1-phosphate in hepatocytes, renal tubular cells, and intestinal mucosa.
Accumulated fructose-1-phosphate causes inhibition of glycogenolysis and gluconeogenesis, resulting in severe hypoglycemia.
Trapping of phosphate in fructose-1-phosphate causes depletion of inorganic phosphate and ATP, impairing cellular metabolism and causing hepatocellular damage.
Metabolic disturbances lead to lactic acidosis, hyperuricemia, and renal tubular dysfunction.
Toxic metabolite accumulation causes hepatomegaly, jaundice, and vomiting after fructose ingestion.
| Involvement | Details |
|---|---|
| Organs | Liver is the main organ affected, showing hepatomegaly, steatosis, and potential acute liver failure due to toxic metabolite accumulation. |
Kidneys may be involved with proximal tubular dysfunction secondary to metabolic disturbances. | |
Small intestine is relevant as the site of dietary fructose absorption, which must be restricted to prevent symptoms. | |
| Tissues | Liver tissue is critically involved as the site of fructose metabolism and damage resulting in hepatomegaly and potential liver failure. |
| Cells | Hepatocytes are the primary cells affected due to accumulation of toxic fructose-1-phosphate causing cellular dysfunction and liver injury. |
| Chemical Mediators | Aldolase B deficiency caused by mutations in the ALDOB gene leads to accumulation of fructose-1-phosphate, which inhibits glycogenolysis and gluconeogenesis. |
Fructose-1-phosphate accumulation causes depletion of inorganic phosphate and ATP, leading to cellular energy failure. |
Treatments
Pharmacological Treatments
Non-pharmacological Treatments
Strict lifelong dietary avoidance of fructose, sucrose, and sorbitol is essential to prevent toxic metabolite accumulation.
Nutritional counseling and monitoring are important to ensure adequate caloric intake and prevent malnutrition.
Supportive care includes management of acute hypoglycemia with intravenous glucose administration.
Prevention
Pharmacological Prevention
There are no approved pharmacological treatments or prophylaxis for hereditary fructose intolerance.
Management focuses on dietary avoidance rather than medication.
Non-pharmacological Prevention
Strict avoidance of dietary fructose, sucrose, and sorbitol is essential to prevent symptoms.
Genetic counseling for affected families to identify carriers and prevent disease.
Early diagnosis through newborn screening or family history to initiate dietary management.
Nutritional support with fructose-free formulas in infants.
Regular monitoring of growth and liver function to prevent complications.
Outcome & Complications
Complications
Severe hypoglycemia leading to seizures or coma if fructose ingestion continues.
Acute liver failure from toxic metabolite accumulation.
Chronic liver damage progressing to fibrosis or cirrhosis.
Growth retardation and developmental delays from chronic malnutrition.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Hereditary Fructose Intolerance versus Galactosemia
Hereditary Fructose Intolerance | Galactosemia |
|---|---|
Symptoms triggered by ingestion of fructose-containing foods such as fruits, honey, or sucrose | Symptoms triggered by ingestion of galactose-containing foods such as milk |
Presents in infants or young children after introduction of fructose, sucrose, or sorbitol | Presents in neonates or infants shortly after starting milk-based feeds |
Deficiency of aldolase B enzyme activity | Deficiency of galactose-1-phosphate uridyltransferase enzyme activity |
Elevated fructose-1-phosphate in liver and blood | Elevated galactose-1-phosphate and reducing substances in urine |
Hereditary Fructose Intolerance versus Essential fructosuria
Hereditary Fructose Intolerance | Essential fructosuria |
|---|---|
Symptomatic with hypoglycemia, vomiting, and liver dysfunction after fructose ingestion | Benign, asymptomatic condition with fructose excreted in urine |
Deficiency of aldolase B enzyme activity | Deficiency of fructokinase enzyme activity |
Presence of fructose-1-phosphate accumulation causing metabolic toxicity | Presence of fructose in urine without metabolic derangements |
Hereditary Fructose Intolerance versus Hereditary fructose intolerance due to fructose-1,6-bisphosphatase deficiency
Hereditary Fructose Intolerance | Hereditary fructose intolerance due to fructose-1,6-bisphosphatase deficiency |
|---|---|
Presents with hypoglycemia and symptoms after fructose ingestion | Presents with hypoglycemia and lactic acidosis during fasting or illness |
Deficiency of aldolase B enzyme activity | Deficiency of fructose-1,6-bisphosphatase enzyme activity |
Elevated fructose-1-phosphate with hypoglycemia and liver dysfunction | Elevated lactate and ketones with hypoglycemia |
Hereditary Fructose Intolerance versus Tyrosinemia type I
Hereditary Fructose Intolerance | Tyrosinemia type I |
|---|---|
Elevated fructose-1-phosphate and hypoglycemia after fructose ingestion | Elevated succinylacetone and tyrosine levels |
Acute symptoms triggered by fructose ingestion with liver dysfunction | Progressive hepatic failure, renal tubular dysfunction, and neurologic crises |
Deficiency of aldolase B enzyme activity | Deficiency of fumarylacetoacetate hydrolase enzyme activity |